Study of management of pasireotide-induced hyperglycemia in adult patients with Cushing’s disease or acromegaly Study of management of pasireotide-induced hyperglycemia in adult patients with Cushing’s disease or ...
A multi-center, randomized, open-label, Phase IV study to investigate the management of pasireotide-induced hyperglycemia with incretin based therapy or insulin in adult patients with Cushing’s disease or acromegaly. A multi-center, randomized, open-label, Phase IV study to investigate the management of pasireotide- ...
Cushing's disease and acromegaly MedDRA version: 19.0;Level: LLT;Classification code 10011651;Term: Cushing's disease;System Organ Class: 100000004860 MedDRA version: 19.0;Classification code 10000600;Term: Acromegaly and gigantism;System Organ Class: 100000004860 ;Therapeutic area: Diseases [C] - Hormonal diseases [C19] Cushing's disease and acromegaly MedDRA version: 19.0;Level: LLT;Classification code 10011651;Term: ...
Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): yes Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...
United States;Belgium;Poland;Turkey;Denmark;Russian Federation;Germany;China